By Global Health & Psychiatry Desk
Published: Autumn 2026
Main Facts
The ongoing, highly polarized public debate surrounding Attention-Deficit/Hyperactivity Disorder (ADHD) has reached a critical juncture following intense media scrutiny and sharp institutional pushback. At the heart of the controversy is a fundamental semantic and scientific confusion: what do we actually mean when we assert that "ADHD is real"?
According to a recent correspondence published in The BMJ—co-authored by researchers Joanna Moncrieff, Lucy Johnstone, James Davies, and colleagues—public discourse and psychiatric institutions routinely conflate three entirely distinct dimensions of reality:
- Experiential Reality: The indisputable, often debilitating day-to-day struggles with concentration, executive dysfunction, impulsivity, and restlessness experienced by millions of individuals.
- Institutional Reality: The administrative, clinical, and legal frameworks—such as official psychiatric diagnostic manuals (e.g., DSM-5)—that classify these behaviors into a recognized diagnostic category, govern treatment access, and shape societal infrastructure.
- Ontological Reality: The contested scientific claim that ADHD represents a discrete, underlying neurobiological and neurodevelopmental entity that causes the observed behaviors.
While psychiatric authorities insist that the biological basis of ADHD is "beyond scientific doubt," critics argue that current neuroimaging and genetic data fall significantly short of proving the ontological claim. Crucially, distinguishing between these categories does not invalidate the suffering of those living with the condition, nor does it argue against providing clinical support. Instead, it challenges the unscientific leap from observing human behavior to pathologizing it as a fixed, deterministic brain disease.
Chronology: How the Debate Unfolded
- August 2026: Channel 4 broadcasts the investigative documentary The Great ADHD Myth?, prompting widespread public conversation regarding the validity of soaring diagnosis rates, the pharmaceutical industry’s role, and the diagnostic criteria used by modern psychiatry.
- August 19, 2026: In direct response to the documentary, the Royal College of Psychiatrists (RCPsych) issues a formal public statement defining ADHD as a "well-established neurodevelopmental disorder" whose legitimacy "should not be questioned." A supplementary blog post, ADHD—Your Questions Answered, asserts: "Whatever you think about ADHD, its scientific basis is not in doubt."
- Late August – September 2026: A coalition of critical psychiatrists, psychologists, and researchers—including Moncrieff, Johnstone, Davies, and colleagues—submit a formal response to The BMJ. They argue that psychiatric leadership is misleading the public by presenting contested institutional hypotheses as settled scientific fact.
- Present Day: The debate continues to reverberate across academic journals, medical panels, and social media platforms, forcing a broader societal reckoning over how modern medicine conceptualizes mental distress, neurodiversity, and behavioral variation.
Supporting Data: What the Evidence Actually Shows
To understand why leading critics are pushing back against institutional certainties, one must look closely at the two primary pillars of evidence cited to prove the ontological reality of ADHD: neuroimaging studies and genetic heritability estimates.
1. The Neuroimaging Mirage
Proponents of the "biological brain disease" model of ADHD frequently point to neuroimaging research (such as fMRI and MRI scans) to argue that the brains of individuals diagnosed with ADHD are structurally or functionally distinct. However, a rigorous examination of the literature reveals a far more nuanced—and less definitive—picture:
- Group-Level vs. Individual-Level Findings: Neuroimaging studies identify, at best, statistical averages across large groups. They do not diagnose individuals. A person with an official ADHD diagnosis may display none of the "average" brain structural differences, while a neurotypical control subject might show them.
- High Rates of Overlap: Brain differences cited in ADHD studies heavily overlap with findings from entirely different psychiatric categories, including depression, anxiety, autism spectrum conditions, and conduct disorders.
- Lack of Specificity: Because neuroimaging cannot isolate a unique, specific neural signature for ADHD, it is scientifically misleading to claim that these scans reveal a distinct "ADHD brain."
2. Misinterpreting Heritability as Genetic Determinism
Another cornerstone of the biological argument is the frequent claim that ADHD is "highly heritable"—often cited as proof that the condition is hardwired into human DNA. Yet, this reflects a fundamental misunderstanding of genetic epidemiology:
- What Heritability Measures: Heritability is a population-level statistical estimate. It calculates how much of the variation in a specific trait within a particular population, under specific environmental conditions, can be attributed to genetic differences.
- The Environment Factor: Heritability estimates are not fixed constants; they change when environments change. Furthermore, high heritability does not imply a simple, linear genetic cause, nor does it rule out the complex, bidirectional interplay between genes and developmental environments.
- The Determinism Fallacy: Concluding that because a trait is heritable, it is therefore hardwired and biologically predetermined is a well-documented scientific error.
Official Responses and Institutional Positions
The fault lines in this debate divide mainstream psychiatric organizations from critical mental health scholars.
- The Royal College of Psychiatrists (RCPsych): Maintaining a staunch defense of current diagnostic paradigms, RCPsych argues that framing ADHD as anything less than a settled neurodevelopmental disorder threatens patient care. Institutional leadership emphasizes that genetic factors, neurological correlations, and the positive responses many individuals have to stimulant medications (such as methylphenidate) validate the biological reality of the condition. In their official statements, they caution that questioning the diagnostic category risks denying patients the validation and accommodations they desperately need.
- Critical Psychiatrists and Psychologists (The BMJ Contributors): The critical camp accuses institutional bodies of engaging in rhetorical sleight-of-hand. By moving uncritically from the experiential reality of human suffering to the ontological reality of a brain disease, medical authorities effectively shut down vital scientific debate. As the BMJ respondents write: "The public are being misinformed by psychiatric institutions and other organisations in claiming that the science is settled. The public deserves to know the real status of the scientific research and have access to alternative ideas and approaches to the problems conceptualised as ADHD."
Broader Implications: Support Without Pathologization
The implications of this controversy extend far beyond academic journals and television documentaries; they touch the lives of millions of children and adults navigating school, work, and healthcare systems.
Breaking the False Dichotomy
A central strategy of institutional defenders is framing the debate as a binary choice: either accept ADHD as a legitimate, biologically determined neurodevelopmental disorder, or dismiss people’s struggles as imaginary, trivial, or unworthy of assistance.
Critics argue this is a false dichotomy. Acknowledging that the biological and ontological claims of ADHD lack definitive proof does not mean the difficulties people face are unreal. Impulsivity, executive dysfunction, and chronic distraction are genuine challenges that can profoundly disrupt a person’s quality of life. However, these difficulties can—and should—be understood and supported based on assessed human need, rather than requiring an unproven psychiatric label to justify care.
The Danger of Closing Down Inquiry
When medical establishments declare that complex behavioral clusters are "beyond scientific doubt," they commit what physicist Richard Feynman famously warned against: the betrayal of scientific inquiry. Science relies on relentless skepticism, the questioning of orthodoxy, and the exploration of alternative hypotheses.
By treating social constructs and diagnostic categories as immutable biological truths, psychiatry risks medicalizing normal human variation, over-relying on pharmacological interventions, and ignoring the profound impact of modern socio-environmental stressors—such as digital hyper-connectivity, economic precarity, and demanding educational environments—that actively produce symptoms of distraction and distress.
Moving Forward
Ultimately, untangling the myths surrounding ADHD allows for a more compassionate and scientifically honest path forward. People seeking help for concentration and organizational challenges deserve validation, practical accommodations, and personalized care. But they also deserve transparency: an honest appraisal of what medical science currently knows, what it does not know, and a willingness to explore multi-dimensional solutions that go far beyond a prescription pad.
